Works by Cherney, David Z. I.

Results: 98

Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono‐ and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double‐blind trial.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 3943, doi. 10.1111/dom.16431

By:

van Baar, Michaël J. B.;
Muskiet, Marcel H. A.;
Scholtes, Rosalie A.;
Touw, Daan J.;
Nieuwdorp, Max;
Kramer, Mark H. H.;
Joles, Jaap A.;
Cherney, David Z. I.;
Bjornstad, Petter;
Krebber, Merle M.;
van Raalte, Daniël H.

Publication type:

Article

Effects of sotagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease stages 3 and 4.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 1010, doi. 10.1111/dom.16079

By:

Sridhar, Vikas S.;
Davies, Michael J.;
Banks, Phillip;
Girard, Manon;
Carroll, Amy K.;
Cherney, David Z. I.

Publication type:

Article

Long‐term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 583, doi. 10.1111/dom.16050

By:

Cosentino, Francesco;
Dagogo‐Jack, Samuel;
Frederich, Robert;
Cannon, Christopher P.;
Cherney, David Z. I.;
Mancuso, James P.;
Wynant, Willy;
Xing, Aiwen;
Gantz, Ira;
Cater, Nilo B.;
Pratley, Richard E.

Publication type:

Article

Effects of ertugliflozin on uric acid and gout‐related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5336, doi. 10.1111/dom.15895

By:

Sridhar, Vikas S.;
Cosentino, Francesco;
Dagogo‐Jack, Samuel;
McGuire, Darren K.;
Pratley, Richard E.;
Cater, Nilo B.;
Noyes Essex, Margaret;
Mancuso, James P.;
Zhao, Yujie;
Cherney, David Z. I.

Publication type:

Article

Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3478, doi. 10.1111/dom.15687

By:

Odutayo, Ayodele;
Cosentino, Francesco;
Pratley, Richard E.;
Dagogo‐Jack, Samuel;
McGuire, Darren K.;
Frederich, Robert;
Fu, Wei;
Cannon, Christopher P.;
Cherney, David Z. I.

Publication type:

Article

An update review of post‐transplant diabetes mellitus: Concept, risk factors, clinical implications and management.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2531, doi. 10.1111/dom.15575

By:

Kanbay, Mehmet;
Copur, Sidar;
Topçu, A. Umur;
Guldan, Mustafa;
Ozbek, Lasin;
Gaipov, Abduzhappar;
Ferro, Charles;
Cozzolino, Mario;
Cherney, David Z. I.;
Tuttle, Katherine R.

Publication type:

Article

Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3410, doi. 10.1111/dom.15203

By:

Cherney, David Z. I.;
Bhatt, Deepak L.;
Szarek, Michael;
Sun, Franklin;
Girard, Manon;
Davies, Michael J.;
Pitt, Bertram;
Steg, Ph. Gabriel

Publication type:

Article

Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator BI 685509 in patients with diabetic kidney disease: A randomized trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2218, doi. 10.1111/dom.15099

By:

Cherney, David Z. I.;
de Zeeuw, Dick;
Heerspink, Hiddo J. L.;
Cardona, Jose;
Desch, Marc;
Wenz, Arne;
Schulze, Friedrich;
Nangaku, Masaomi

Publication type:

Article

Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1646, doi. 10.1111/dom.15019

By:

Cherney, David Z. I.;
Ferrannini, Ele;
Umpierrez, Guillermo E.;
Peters, Anne L.;
Rosenstock, Julio;
Powell, David R.;
Davies, Michael J.;
Banks, Phillip;
Agarwal, Rajiv

Publication type:

Article

Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1398, doi. 10.1111/dom.14965

By:

Kim, Joseph M.;
Bhatt, Deepak L.;
Dagogo‐Jack, Samuel;
Cherney, David Z. I.;
Cosentino, Francesco;
McGuire, Darren K.;
Pratley, Richard E.;
Liu, Chih‐Chin;
Cater, Nilo B.;
Frederich, Robert;
Mancuso, James P.;
Cannon, Christopher P.

Publication type:

Article

Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1829, doi. 10.1111/dom.14769

By:

Segar, Matthew W.;
Kolkailah, Ahmed A.;
Frederich, Robert;
Pong, Annpey;
Cannon, Christopher P.;
Cosentino, Francesco;
Dagogo‐Jack, Samuel;
McGuire, Darren K.;
Pratley, Richard E.;
Liu, Chih‐Chin;
Maldonado, Mario;
Liu, Jie;
Cater, Nilo B.;
Pandey, Ambarish;
Cherney, David Z. I.

Publication type:

Article

Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1578, doi. 10.1111/dom.14729

By:

Sen, Taha;
Scholtes, Rosalie;
Greasley, Peter J.;
Cherney, David Z. I.;
Dekkers, Claire C. J.;
Vervloet, Marc;
Danser, Alexander H. J.;
Barbour, Sean J.;
Karlsson, Cecilia;
Hammarstedt, Ann;
Li, Qiang;
Laverman, Gozewijn D.;
Bjornstad, Petter;
van Raalte, Daniel H.;
Heerspink, Hiddo J. L.

Publication type:

Article

Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1245, doi. 10.1111/dom.14691

By:

Dagogo‐Jack, Samuel;
Cannon, Christopher P.;
Cherney, David Z. I.;
Cosentino, Francesco;
Liu, Jie;
Pong, Annpey;
Gantz, Ira;
Frederich, Robert;
Mancuso, James P.;
Pratley, Richard E.

Publication type:

Article

The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CV.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1114, doi. 10.1111/dom.14677

By:

Cherney, David Z. I.;
Cosentino, Francesco;
Pratley, Richard E.;
Dagogo‐Jack, Samuel;
Frederich, Robert;
Maldonado, Mario;
Liu, Jie;
Pong, Annpey;
Liu, Chih‐Chin;
Cannon, Christopher P.

Publication type:

Article

Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2632, doi. 10.1111/dom.14513

By:

Cherney, David Z. I.;
Ferrannini, Ele;
Umpierrez, Guillermo E.;
Peters, Anne L.;
Rosenstock, Julio;
Carroll, Amy K.;
Lapuerta, Pablo;
Banks, Phillip;
Agarwal, Rajiv

Publication type:

Article

Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 11, p. 2466, doi. 10.1111/dom.14489

By:

Liu, Hongyan;
Sridhar, Vikas S.;
Montemayor, Daniel;
Lovblom, Leif Erik;
Lytvyn, Yuliya;
Ye, Hongping;
Kim, Jiwan;
Ali, Mir Tariq;
Scarr, Daniel;
Lawler, Patrick R.;
Perkins, Bruce A.;
Sharma, Kumar;
Cherney, David Z. I.

Publication type:

Article

Renal hyperfiltration defined by high estimated glomerular filtration rate: A risk factor for cardiovascular disease and mortality.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2368, doi. 10.1111/dom.13831

By:

Kanbay, Mehmet;
Ertuglu, Lale A.;
Afsar, Baris;
Ozdogan, Elif;
Kucuksumer, Zeynep S.;
Ortiz, Alberto;
Covic, Adrian;
Kuwabara, Masanari;
Cherney, David Z. I.;
Raalte, Daniel H.;
Zeeuw, Dick

Publication type:

Article

Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1388, doi. 10.1111/dom.13665

By:

Lytvyn, Yuliya;
Singh, Sunita K.;
Lai, Vesta;
Tse, Josephine;
Cham, Leslie;
Cherney, David Z. I.;
Advani, Andrew;
Sochett, Etienne;
Bjornstad, Petter;
Lovshin, Julie A.;
Boulet, Genevieve;
Farooqi, Mohammed A.;
Weisman, Alanna;
Perkins, Bruce A.;
Lovblom, Leif E.;
Keenan, Hillary A.;
Brent, Michael H.;
Paul, Narinder;
Bril, Vera

Publication type:

Article

Sodium glucose cotransporter (SGLT)‐2 inhibitors: Do we need them for glucose‐lowering, for cardiorenal protection or both?

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, p. 24, doi. 10.1111/dom.13692

By:

Scholtes, Rosalie A.;
Baar, Michaël J. B.;
Lytvyn, Yuliya;
Bjornstad, Petter;
Nieuwdorp, Max;
Cherney, David Z. I.;
Raalte, Daniël H.

Publication type:

Article

The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 575, doi. 10.1111/dom.13556

By:

Bjornstad, Petter;
Singh, Sunita K.;
Snell‐Bergeon, Janet K.;
Lovshin, Julie A.;
Lytvyn, Yuliya;
Lovblom, Leif E.;
Rewers, Marian J.;
Boulet, Genevieve;
Lai, Vesta;
Tse, Josephine;
Cham, Leslie;
Orszag, Andrej;
Weisman, Alanna;
Keenan, Hillary A.;
Brent, Michael H.;
Paul, Narinder;
Bril, Vera;
Perkins, Bruce A.;
Cherney, David Z. I.

Publication type:

Article

Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6.

Published in:

Nephrology Dialysis Transplantation, 2025, v. 40, n. 2, p. 352, doi. 10.1093/ndt/gfae150

By:

Apperloo, Ellen M;
Cherney, David Z I;
Kuhlman, Anja Birk;
Mann, Johannes F E;
Rasmussen, Søren;
Rossing, Peter;
Tuttle, Katherine R;
Vrhnjak, Blaz;
Heerspink, Hiddo J L

Publication type:

Article

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.

Published in:

Nephrology Dialysis Transplantation, 2025, v. 40, n. 2, p. 308, doi. 10.1093/ndt/gfae132

By:

Heerspink, Hiddo J L;
Agarwal, Rajiv;
Bakris, George L;
Cherney, David Z I;
Lam, Carolyn S P;
Neuen, Brendon L;
Sarafidis, Pantelis A;
Tuttle, Katherine R;
Wanner, Christoph;
Brinker, Meike D;
Dizayee, Sara;
Kolkhof, Peter;
Schloemer, Patrick;
Vesterinen, Paula;
Perkovic, Vlado;
investigators, for the FIND-CKD

Publication type:

Article

Upcoming drug targets for kidney protective effects in chronic kidney disease.

Published in:

Nephrology Dialysis Transplantation, 2025, v. 40, p. i47, doi. 10.1093/ndt/gfae216

By:

Nardone, Massimo;
Yau, Kevin;
Kugathasan, Luxcia;
Odutayo, Ayodele;
Mohsen, Mai;
Ouimet, Jean-Philippe;
Sridhar, Vikas S;
Cherney, David Z I

Publication type:

Article

Volenrelaxin (LY3540378) increases renal plasma flow: a randomized Phase 1 trial.

Published in:

Nephrology Dialysis Transplantation, 2025, v. 40, n. 1, p. 109, doi. 10.1093/ndt/gfae112

By:

Tham, Lai San;
Heerspink, Hiddo J L;
Wang, Xiaojun;
Verdino, Petra;
Saifan, Chadi G;
Benson, Eric A;
Goldsmith, Paul;
Wang, Zhenzhong;
Testani, Jeffrey M;
Haupt, Axel;
Sam, Flora;
Cherney, David Z I

Publication type:

Article

Proximal versus distal diuretics in congestive heart failure.

Published in:

Nephrology Dialysis Transplantation, 2024, v. 39, n. 9, p. 1392, doi. 10.1093/ndt/gfae058

By:

Nardone, Massimo;
Sridhar, Vikas S;
Yau, Kevin;
Odutayo, Ayodele;
Cherney, David Z I

Publication type:

Article

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.

Published in:

Nephrology Dialysis Transplantation, 2020, v. 35, n. 10, p. 1700, doi. 10.1093/ndt/gfaa234

By:

Wheeler, David C;
Stefansson, Bergur V;
Batiushin, Mikhail;
Bilchenko, Oleksandr;
Cherney, David Z I;
Chertow, Glenn M;
Douthat, Walter;
Dwyer, Jamie P;
Escudero, Elizabeth;
Pecoits-Filho, Roberto;
Furuland, Hans;
Górriz, José Luis;
Greene, Tom;
Haller, Hermann;
Hou, Fan Fan;
Kang, Shin-Wook;
Isidto, Rey;
Khullar, Dinesh;
Mark, Patrick B;
McMurray, John J V

Publication type:

Article

The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial.

Published in:

Nephrology Dialysis Transplantation, 2020, v. 35, n. 5, p. 895, doi. 10.1093/ndt/gfz294

By:

Opingari, Erika;
Verma, Subodh;
Connelly, Kim A;
Mazer, Cyril David;
Teoh, Hwee;
Quan, Adrian;
Zuo, Fei;
Pan, Yi;
Bhatt, Deepak L;
Zinman, Bernard;
Leiter, Lawrence A;
Yan, Andrew T;
Cherney, David Z I;
Gilbert, Richard E

Publication type:

Article

Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study.

Published in:

Nephrology Dialysis Transplantation, 2018, v. 33, n. 7, p. 1189, doi. 10.1093/ndt/gfx255

By:

Bjornstad, Petter;
Pyle, Laura;
Cherney, David Z I;
Johnson, Richard J;
Sippl, Rachel;
Wong, Randy;
Rewers, Marian;
Snell-Bergeon, Janet K

Publication type:

Article

Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes.

Published in:

Renal Failure, 2019, v. 41, n. 1, p. 427, doi. 10.1080/0886022X.2019.1614057

By:

Sekercioglu, Nigar;
Lovblom, Leif Erik;
Bjornstad, Petter;
Lovshin, Julie A.;
Lytvyn, Yuliya;
Boulet, Geneviève;
Farooqi, Mohammed A.;
Orszag, Andrej;
Lai, Vesta;
Tse, Josephine;
Cham, Leslie;
Keenan, Hillary A.;
Brent, Michael H.;
Paul, Narinder;
Bril, Vera;
Perkins, Bruce A.;
Cherney, David Z. I.

Publication type:

Article

Cardiorenal Protection in Diabetic Kidney Disease.

Published in:

Endocrinology & Metabolism, 2021, v. 36, n. 2, p. 256, doi. 10.3803/EnM.2021.987

By:

Lee, Jason F.;
Berzan, Ecaterina;
Sridhar, Vikas S.;
Odutayo, Ayodele;
Cherney, David Z. I.

Publication type:

Article

FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes.

Published in:

American Journal of Managed Care, 2021, v. 27, p. S375, doi. 10.37765/ajmc.2021.88808

By:

Pochopień, Michał T.;
Cherney, David Z. I.;
Folkerts, Kerstin;
Levy, Pierre;
Millier, Aurélie;
Morris, Stephen;
Roy-Chaudhury, Prabir;
Sullivan, Sean D.;
Mernagh, Paul

Publication type:

Article

Cardiovascular disease in chronic kidney disease Open Access.

Published in:

European Heart Journal, 2025, v. 46, n. 23, p. 2148, doi. 10.1093/eurheartj/ehaf167

By:

Marx-Schütt, Katharina;
Cherney, David Z I;
Jankowski, Joachim;
Matsushita, Kunihiro;
Nardone, Massimo;
Marx, Nikolaus

Publication type:

Article

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial.

Published in:

European Heart Journal, 2025, v. 46, n. 12, p. 1096, doi. 10.1093/eurheartj/ehae613

By:

Mahaffey, Kenneth W;
Tuttle, Katherine R;
Arici, Mustafa;
Baeres, Florian M M;
Bakris, George;
Charytan, David M;
Cherney, David Z I;
Chernin, Gil;
Correa-Rotter, Ricardo;
Gumprecht, Janusz;
Idorn, Thomas;
Pugliese, Giuseppe;
Rasmussen, Ida Kirstine Bull;
Rasmussen, Søren;
Rossing, Peter;
Sokareva, Ekaterina;
Mann, Johannes F E;
Perkovic, Vlado;
Pratley, Richard

Publication type:

Article

Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.

Published in:

European Heart Journal, 2023, v. 44, n. 48, p. 5163, doi. 10.1093/eurheartj/ehad639

By:

Pandey, Ambarish;
Kolkailah, Ahmed A;
Cosentino, Francesco;
Cannon, Christopher P;
Frederich, Robert C;
Cherney, David Z I;
Dagogo-Jack, Samuel;
Pratley, Richard E;
Cater, Nilo B;
Gantz, Ira;
Mancuso, James P;
McGuire, Darren K

Publication type:

Article

Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Published in:

2019

By:

Lovshin, Julie A.;
Lytvyn, Yuliya;
Lovblom, Leif E.;
Katz, Alexandra;
Boulet, Geneviève;
Bjornstad, Petter;
Lai, Vesta;
Cham, Leslie;
Tse, Josephine;
Orszag, Andrej;
Keenan, Hillary A.;
Paul, Narinder;
Bril, Vera;
Wong, David T.;
McReelis, Kylen D.;
Brent, Michael H.;
Perkins, Bruce A.;
Cherney, David Z. I.

Publication type:

journal article

Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.

Published in:

2019

By:

Bjornstad, Petter;
Wiromrat, Pattara;
Johnson, Richard J.;
Sippl, Rachel;
Cherney, David Z. I.;
Wong, Randy;
Rewers, Marian J.;
Snell-Bergeon, Janet K.

Publication type:

journal article

Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Published in:

Diabetes Care, 2018, v. 41, n. 12, p. 2570, doi. 10.2337/dc18-1236

By:

Lovshin, Julie A.;
Bjornstad, Petter;
Lovblom, Leif E.;
Bai, Johnny-Wei;
Lytvyn, Yuliya;
Boulet, Geneviève;
Farooqi, Mohammed A.;
Santiago, Sam;
Orszag, Andrej;
Scarr, Daniel;
Weisman, Alanna;
Keenan, Hillary A.;
Brent, Michael H.;
Paul, Narinder;
Bril, Vera;
Perkins, Bruce A.;
Cherney, David Z. I.

Publication type:

Article

Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Published in:

2018

By:

Lovshin, Julie A;
Bjornstad, Petter;
Lovblom, Leif E;
Bai, Johnny-Wei;
Lytvyn, Yuliya;
Boulet, Geneviève;
Farooqi, Mohammed A;
Santiago, Sam;
Orszag, Andrej;
Scarr, Daniel;
Weisman, Alanna;
Keenan, Hillary A;
Brent, Michael H;
Paul, Narinder;
Bril, Vera;
Perkins, Bruce A;
Cherney, David Z I

Publication type:

journal article

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes.

Published in:

2018

By:

Bjornstad, Petter;
Laffel, Lori M.;
Tamborlane, William V.;
Simons, Gudrun;
Hantel, Stefan;
Von Eynatten, Maximilian;
George, Jyothis T.;
Marquard, Jan;
Cherney, David;
Laffel, Lori;
George, Jyothis;
Cherney, David Z I

Publication type:

Letter

Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Published in:

Diabetes Care, 2018, v. 41, n. 4, p. 831, doi. 10.2337/dc17-2475

By:

Bjornstad, Petter;
Lovshin, Julie A.;
Lytvyn, Yuliya;
Boulet, Genevieve;
Lovblom, Leif E.;
Alhuzaim, Omar N.;
Farooqi, Mohammed A.;
Lai, Vesta;
Tse, Josephine;
Cham, Leslie;
Orszag, Andrej;
Scarr, Daniel;
Weisman, Alanna;
Keenan, Hillary A.;
Brent, Michael H.;
Paul, Narinder;
Bril, Vera;
Perkins, Bruce A.;
Cherney, David Z. I.

Publication type:

Article

RESPONSE TO COMMENT ON LOVSHIN ET AL. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α1-67 in Patients With Type 2 Diabetes. Diabetes Care 2017;40:1073-1081.

Published in:

Diabetes Care, 2017, v. 40, n. 11, p. e159, doi. 10.2337/dci17-0033

By:

Lovshin, Julie A.;
Lovblom, Leif E.;
Cherney, David Z. I.

Publication type:

Article

Erratum. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α1-67 in Patients With Type 2 Diabetes. Diabetes Care 2017;40:1073-1081.

Published in:

2017

By:

Lovshin, Julie A;
Rajasekeran, Harindra;
Lytvyn, Yulyia;
Lovblom, Leif E;
Khan, Shajiha;
Alemu, Robel;
Locke, Amy;
Lai, Vesta;
He, Huaibing;
Hittle, Lucinda;
Wang, Weixun;
Drucker, Daniel J;
Cherney, David Z I

Publication type:

journal article

Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α1-67 in Patients With Type 2 Diabetes.

Published in:

2017

By:

Lovshin, Julie A.;
Rajasekeran, Harindra;
Lytvyn, Yulyia;
Lovblom, Leif E.;
Khan, Shajiha;
Alemu, Robel;
Locke, Amy;
Lai, Vesta;
He, Huaibing;
Hittle, Lucinda;
Weixun Wang;
Drucker, Daniel J.;
Cherney, David Z. I.;
Wang, Weixun

Publication type:

journal article

Use of Canagliflozin in Kidney Transplant Recipients for the Treatment of Type 2 Diabetes: A Case Series.

Published in:

2017

By:

Rajasekeran, Harindra;
Kim, S. Joseph;
Cardella, Carl J.;
Schiff, Jeffrey;
Cattral, Mark;
Cherney, David Z. I.;
Singh, Sunita K. S.

Publication type:

Letter

Association Between Plasma Uric Acid Levels and Cardiorenal Function in Adolescents With Type 1 Diabetes.

Published in:

2016

By:

Lytvyn, Yuliya;
Mahmud, Farid H.;
Daneman, Denis;
Deda, Livia;
Dunger, David B.;
Deanfield, John;
Dalton, R. Neil;
Elia, Yesmino;
Har, Ronnie;
Bradley, Timothy J.;
Slorach, Cameron;
Wei Hui;
Moineddin, Rahim;
Reich, Heather N.;
Scholey, James W.;
Mertens, Luc;
Sochett, Etienne;
Cherney, David Z. I.;
Hui, Wei

Publication type:

journal article

Renal Hyperfiltration Is Associated With Glucose-Dependent Changes in Fractional Excretion of Sodium in Patients With Uncomplicated Type 1 Diabetes.

Published in:

Diabetes Care, 2014, v. 37, n. 10, p. 2774, doi. 10.2337/dc14-0798

By:

Yang, Gary K.;
Har, Ronnie L. H.;
Lytvyn, Yuliya;
Yip, Paul;
Cherney, David Z. I.

Publication type:

Article

Sodium-Glucose Cotransporter 2 Inhibition and Glycemic Control in Type 1 Diabetes: Results of an 8-Week Open-Label Proof-of-Concept Trial.

Published in:

Diabetes Care, 2014, v. 37, n. 5, p. 1480, doi. 10.2337/dc13-2338

By:

Perkins, Bruce A.;
Cherney, David Z. I.;
Partridge, Helen;
Soleymanlou, Nima;
Tschirhart, Holly;
Zinman, Bernard;
Fagan, Nora M.;
Kaspers, Stefan;
Woerle, Hans-Juergen;
Broedl, Uli C.;
Johansen, Odd-Erik

Publication type:

Article

Sex Differences in Renal Responses to Hyperglycemia, L-Arginine, and L-NMMA in Humans With Uncomplicated Type 1 Diabetes.

Published in:

Diabetes Care, 2013, v. 36, n. 5, p. 1290, doi. 10.2337/dc12-1305

By:

CHERNEY, DAVID Z. I.;
SCHOLEY, JAMES W.;
SOCHETT, ETIENNE B.

Publication type:

Article

The Effect of Direct Renin Inhibition Alone and in Combination With ACE Inhibition on Endothelial Function, Arterial Stiffness, and Renal Function in Type 1 Diabetes.

Published in:

Diabetes Care, 2012, v. 35, n. 11, p. 2324, doi. 10.2337/dc12-0773

By:

CHERNEY, DAVID Z. I.;
SCHOLEY, JAMES W.;
SHAN JIANG;
HAR, RONNIE;
LAI, VESTA;
SOCHETT, ETIENNE B.;
REICH, HEATHER N.

Publication type:

Article

Response to Comment on: Cherney and Sochett. Evolution of Renal Hyperfiltration and Arterial Stiffness From Adolescence Into Early Adulthood in Type 1 Diabetes. Diabetes Care 2011;34: 1821-1826.

Published in:

2011

By:

SU CHI LIM;
TAN, CLARA S. H.;
CHERNEY, DAVID Z. I.;
SOCHETT, ETIENNE B.

Publication type:

Letter